Biocon Ltd. Financials

NSE BSE

15:58 Sep 12

Biocon Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

365.20

+1.15 (+0.32%)

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology

365.20

+1.15 (+0.32%)
15:58 Sep 12

Quality

55/100
High Financial Strength

Valuation

42/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	8184	11174.2	14755.7	15261.7	15770.7
Operating Expenses +	6213.8	8662.5	11457	12095.4	12506.4
Raw Material	2975	3817.2	5754.6	4903.3	5695.8
Increase Decrease in Cost	-256.6	-154.1	-856.7	294.2	-275.9
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1880.1	2181	2664.1	3144.4	3222.1
Miscellaneous Expenses	1937.5	4070.6	5260.4	5006.7	3864.4
Operating Profit	1970.2	2511.7	3298.7	3166.3	3264.3
Other Income	212.7	375.9	865.5	1208.2	183.9
Depreciation	814.2	1113.1	1568.8	1687	1736.6
Interest	67.6	419	974.4	897.4	938.1
Profit before tax and exceptio..	1301.1	1355.5	1621	1790.1	773.5
Exceptional Items	-111.1	-291.4	-11.6	96.5	64.5
PBT	1190	1064.1	1609.4	1886.6	709
Provision for Taxation	211.5	254.1	227.4	457.2	181.2
Net Profit	978.5	810	1382	1429.4	656.8
NET Profit after MI	648.4	462.7	1022.5	1013.3	385
EPS	5.42	3.88	8.55	8.46	3.22
Operating Profit Margin (%)	24.07	22.48	22.36	20.75	20.7
Net Profit Margin (%)	7.92	4.14	6.93	6.64	2.44

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	54.40	60.60	60.60	60.60	60.60
FII	6.00	5.70	5.70	5.90	5.90
MF	15.20	8.80	8.60	8.00	8.70
Others	7.70	6.90	6.70	6.50	5.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: